Why shares in this ASX environmental company have soared 9% today

Here's a closer look at why the Phoslock Environmental Technologies Ltd (ASX: PET) share price is soaring today.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Phoslock Environmental Technologies Ltd (ASX: PET) share price is up 9.5% at the time of writing following an update to the market earlier this morning on its operations in China, as well as the announcement of a new project in Brazil.

What does Phoslock do?

Phoslock is an international environmental company specialising in engineering solutions and water treatment products to remediate polluted lakes, rivers, canals and drinking water reservoirs. Phoslock has its headquarters in Sydney with offices in Brisbane, Beijing and Changxing, China, and Manchester, UK.

In 2017, Phoslock (Beijing) was formed to help remediate the massive Chinese algae and water pollution problem. Phoslock owns the patent for Phoslock, a water treatment product that inhibits the growth of harmful algal blooms (HAB) that lead to detrimental effects to both aquatic and human life. Phoslock (the product) is certified to be used in drinking water in North America, Europe, UK, Brazil, Australia and China.

The Phoslock share price has increased by over 100% during the past 12 months, peaking last August at a high of $1.52. It has since retreated, and has recently come under pressure due to coronavirus concerns. Phoslock shares are currently sitting at $0.81 with today's gains.

China update

Phoslock announced that its Beijing office is now back at work, with government approval to re-start its factory. It anticipates that production should ramp up over the next month. It noted that it has inventory held outside China to last until mid-year.

Phoslock has no treatments in China planned until late March to April and no delays are expected. It also notes there is no effect on FY2020 sales guidance.

Details of new Brazil project

Phoslock also announced that through its Brazilian licensee, Phoslock has received a contract from CEDEA to treat one of Rio de Janeiro city's main drinking reservoirs. The application has already commenced and will continue for the next 3 months, with an estimated value of over $2 million.

The company commented that this is a further instance of a growing number of local and government authorities in a range of countries having full confidence in using Phoslock in human drinking water reservoirs.

Phoslock further commented that Rio de Janeiro's high profile has generated substantial media coverage of this problem both in Brazil and internationally. Consequently, it believes that the application of Phoslock to this reservoir is likely to lead to similar applications elsewhere in Brazil and in other countries, as this particular problem is widespread.

Chair Laurence Freedman AM commented: "With each successful application of Phoslock in lakes, dams and reservoirs, our ability to dramatically transform heavily polluted waterbodies – even those suffering from eutrophication – adds to increasing global acceptance and demand for our services."

Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A young well-dressed couple at a luxury resort celebrate successful life choices.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors kept up the selling this session.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Morgans says these ASX 200 shares can rise 20%+

The broker says these shares could offer major upside.

Read more »

Three women athletes lie flat on a running track as though they have had a long hard race where they have fought hard but lost the event.
Broker Notes

Brokers rate 2 ASX All Ords rippers of 2025: Is their phenomenal run over?

Both of these ASX shares more than tripled in value last year.

Read more »

a woman puts her hand to her chin and looks to the side deep in thought as though pondering something significant.
Broker Notes

2 ASX 200 gold shares to buy and 1 to sell: experts

After exceptional share price growth for 2 years, experts say investors need to choose their gold stocks carefully.

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why 4DMedical, ARB, Inghams, and Qoria shares are tumbling today

These shares are under pressure on Tuesday. What's going on?

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Market News

Why Bellevue Gold, DroneShield, Hub24, and Telix shares are storming higher today

These shares are rising on Tuesday despite the market weakness.

Read more »

Keyboard button with the word sell on it, symbolising the time being right to sell ASX stocks.
Resources Shares

ASX 200 materials was the best sector of 2025 but it's time to sell these 3 shares: broker

Morgan Stanley has just updated its ratings and 12-month price targets on 3 ASX 200 mining shares.

Read more »

A red heart-shaped balloon float up above the plain white ones, indicating the best shares
Dividend Investing

Why this could be the best ASX dividend stock to buy today

There are few ideas that match this option for dividend investors.

Read more »